Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
18 , e0284837 (2023)
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial
The body can naturally produce glycine, however dietary intake and supplementation can be beneficial, particularly during periods of increased physiological demand such as ageing, illness, intense physical activity, or tissue repair
US Food and Drug Administration
These products are not intended to diagnose, treat, cure, or prevent any diseases
US$ 28.38
US$ 26.39
US$ 22.24
US$ 26.14
US$ 24.34
US$ 25.29
US$ 23.77
